Frequency of Combined ER, PR, and HER-2 Biomarkers in Breast Cancer

5.5 KB of tabular data on the co-occurrence of key breast cancer biomarkers. Heba Mohammed Arafat published this dataset under a CC-BY-4.0 license on figshare, with a last update timestamp of 2026-06-01. The data likely contains counts or percentages for combinations of estrogen receptor, progesterone receptor, and HER-2 status.

Use Cases

• Analyzing the prevalence of triple-negative breast cancer based on the combined absence of ER, PR, and HER-2.
• Studying the correlation between ER and PR status based on their co-occurrence frequencies.
• Modeling patient subgroups for treatment response based on combined biomarker profiles mentioned in the description.

Strengths

• Dataset is openly licensed under CC-BY-4.0.
• File size is precisely 5.5 KB, indicating a focused scope.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.

Provenance

Source

figshare, author Heba Mohammed Arafat.

Freshness

Last updated 2026-06-01 17:31:33; freshness should be verified.